Pembrolizumab (Keytruda®)

Pembrolizumab is an immunotherapy drug that works with the body’s immune system to detect and fight cancer cells. It is used in combination with chemotherapy to treat high-risk, early-stage triple-negative breast cancer and to treat triple-negative breast cancers that test positive for the protein PD-L1 and are either inoperable (can’t undergo surgery) or are metastatic. It’s administered through an IV.